Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.080 | 13 | 46837850 | intron variant | A/G | snv | 0.69 |
|
Mental Disorders | 0.030 | 1.000 | 3 | 2011 | 2019 | |||||||
|
0.807 | 0.080 | 13 | 46837850 | intron variant | A/G | snv | 0.69 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 13 | 46890902 | intron variant | G/C;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.120 | 13 | 46867572 | intron variant | T/C;G | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.040 | 13 | 46881488 | intron variant | A/C | snv | 1.4E-03 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 13 | 46849983 | intron variant | A/G | snv | 0.11 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.120 | 13 | 46847701 | intron variant | C/T | snv | 0.12 |
|
Infections; Musculoskeletal Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
1.000 | 0.120 | 13 | 46847701 | intron variant | C/T | snv | 0.12 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 13 | 46848951 | intron variant | T/C | snv | 0.43 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
13 | 46849156 | intron variant | C/T | snv | 0.64 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.040 | 13 | 46873101 | intron variant | G/A | snv | 0.49 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
13 | 46893491 | intron variant | G/A | snv | 0.37 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
0.925 | 0.080 | 13 | 46854336 | intron variant | A/C | snv | 0.70 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 13 | 46854336 | intron variant | A/C | snv | 0.70 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 13 | 46854336 | intron variant | A/C | snv | 0.70 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 13 | 46854336 | intron variant | A/C | snv | 0.70 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.040 | 13 | 46860971 | intron variant | C/G | snv | 0.18 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.040 | 13 | 46845442 | intron variant | A/G | snv | 0.19 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.040 | 13 | 46883917 | intron variant | C/A;G | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
1.000 | 0.040 | 13 | 46883917 | intron variant | C/A;G | snv |
|
0.010 | 1.000 | 1 | 2006 | 2006 | |||||||||
|
1.000 | 0.040 | 13 | 46883917 | intron variant | C/A;G | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
1.000 | 0.040 | 13 | 46854476 | intron variant | T/C | snv | 0.27 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 13 | 46846177 | intron variant | T/C | snv | 0.60 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
13 | 46849989 | intron variant | G/A | snv | 6.4E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
13 | 46849989 | intron variant | G/A | snv | 6.4E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 |